Literature DB >> 21256946

Enhanced permeation of fentanyl from supersaturated solutions in a model membrane.

P Santos1, A C Watkinson, J Hadgraft, M E Lane.   

Abstract

The aim of the present study was to investigate the permeation of fentanyl from supersaturated formulations when applied to silicone membrane. Silicone was chosen in order to separate the effects of supersaturation from other possible influences of volatile formulation components on biological membranes. Supersaturated formulations containing either propylene glycol/water (PG/H(2)O) or propylene glycol/ethanol (PG/Et) were prepared containing varying degrees of saturation (DS) of fentanyl. Permeation of finite and infinite doses of the PG/H(2)O formulations, and finite doses of the PG/Et formulations was investigated using Franz-type diffusion cells. For the PG/H(2)O formulations a good correlation between the flux and the DS of the formulation up to 5 DS for infinite dose studies (r(2)=0.99), and up to 7 DS for finite dose studies (r(2)=0.98), was evident. Similarly, for the PG/Et formulations there is a good correlation between the mean flux and the theoretical DS of the formulation (r(2)=0.95). Except for the 2 DS formulations, no significant differences were seen in the mean flux between PG/H(2)O and PG/Et finite dose studies. The larger fluxes observed for infinite doses of the PG/H(2)O formulations versus finite doses reflect changes in the effective area of diffusion over the time of the experiment for the latter set of experiments. The permeation enhancement observed for PG/Et formulations confirms that enhanced drug thermodynamic activity was induced by ethanol evaporation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256946     DOI: 10.1016/j.ijpharm.2011.01.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs.

Authors:  Shweta A Raina; Geoff G Z Zhang; David E Alonzo; Jianwei Wu; Donghua Zhu; Nathaniel D Catron; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-05-28       Impact factor: 4.200

2.  Imaging drug delivery to skin with stimulated Raman scattering microscopy.

Authors:  Brian G Saar; L Rodrigo Contreras-Rojas; X Sunney Xie; Richard H Guy
Journal:  Mol Pharm       Date:  2011-05-17       Impact factor: 4.939

3.  Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients.

Authors:  Marianne Lind; Kim Troensegaard Nielsen; Line Hollesen Schefe; Kasper Nørremark; André Huss Eriksson; Hanne Norsgaard; Brian Thoning Pedersen; Karsten Petersson
Journal:  Dermatol Ther (Heidelb)       Date:  2016-06-29

4.  Increased Therapeutic Efficacy of SLN Containing Etofenamate and Ibuprofen in Topical Treatment of Inflammation.

Authors:  Giuliana Mancini; Lídia M D Gonçalves; Joana Marto; Filomena A Carvalho; Sandra Simões; Helena Margarida Ribeiro; António J Almeida
Journal:  Pharmaceutics       Date:  2021-03-03       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.